April 12, 2024

FDA Roundup: April 12, 2024

For Immediate Release: April 12, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the […]
April 12, 2024

We Are Hiring

Are you looking for an exciting and rewarding career in the federal government?  Would you like to make a difference in how prescription drugs, including new […]
April 12, 2024

FDA Drug Safety Podcasts

FDA adds Boxed Warning for increased risk of severe hypocalcemia in patients with advanced chronic kidney disease taking osteoporosis medicine Prolia (denosumab) Yes January 19, 2024 […]
April 12, 2024

List of Determinations Including Written Request

Abacavir/ dolutegravir/ lamivudine ViiV Healthcare Company 6/7/2023 Abatacept BMS 2/14/2017  Acetaminophen Mallinckrodt 7/11/2016 Afatinib  Boehringer Ingelheim Pharmaceuticals, Inc. 3/8/2022 Aflibercept Regeneron Pharmaceuticals 10/18/2022 Albuterol GlaxoSmithKline 8/27/2008 […]
April 12, 2024

FDA Listing of Authorized Generics

Updated April 11, 2024 Note:This list of authorized generic drugs (AGs) was created from a manual review of FDA’s database of annual reports submitted to the […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0